PepsiCo and Coca-Cola enter hard soda markets, causing concerns among regulators and researchers.
NYT > Health
Related Posts
CVS and Walgreens Near $10 Billion Deal to Settle Opioid Cases
The dual agreements would resolve thousands of lawsuits over the retailers’ role in the addiction crisis. But a large majority of state, local and tribal governments must sign on. NYT > Health
With Promise of Legalization, Psychedelic Companies Joust Over Future Profits
Cash rich start-ups are filing scores of patent claims on hallucinogens like magic mushrooms. Researchers and patient advocates worry high prices will make the therapies unaffordable. NYT > Health
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S. NYT > Health